410 related articles for article (PubMed ID: 29802960)
21. Targeting methyltransferase PRMT5 eliminates leukemia stem cells in chronic myelogenous leukemia.
Jin Y; Zhou J; Xu F; Jin B; Cui L; Wang Y; Du X; Li J; Li P; Ren R; Pan J
J Clin Invest; 2016 Oct; 126(10):3961-3980. PubMed ID: 27643437
[TBL] [Abstract][Full Text] [Related]
22. Tumor suppressor PLZF regulated by lncRNA ANRIL suppresses proliferation and epithelial mesenchymal transformation of gastric cancer cells.
Wang JB; Jin Y; Wu P; Liu Y; Zhao WJ; Chen JF; De W; Yang F
Oncol Rep; 2019 Feb; 41(2):1007-1018. PubMed ID: 30431129
[TBL] [Abstract][Full Text] [Related]
23. Protein arginine methyltransferase 5 promotes lung cancer metastasis via the epigenetic regulation of miR-99 family/FGFR3 signaling.
Jing P; Zhao N; Ye M; Zhang Y; Zhang Z; Sun J; Wang Z; Zhang J; Gu Z
Cancer Lett; 2018 Jul; 427():38-48. PubMed ID: 29679612
[TBL] [Abstract][Full Text] [Related]
24. Protein arginine methyltransferase 5 (PRMT5) activates WNT/β-catenin signalling in breast cancer cells via epigenetic silencing of DKK1 and DKK3.
Shailesh H; Siveen KS; Sif S
J Cell Mol Med; 2021 Feb; 25(3):1583-1600. PubMed ID: 33462997
[TBL] [Abstract][Full Text] [Related]
25. REC8 functions as a tumor suppressor and is epigenetically downregulated in gastric cancer, especially in EBV-positive subtype.
Yu J; Liang Q; Wang J; Wang K; Gao J; Zhang J; Zeng Y; Chiu PW; Ng EK; Sung JJ
Oncogene; 2017 Jan; 36(2):182-193. PubMed ID: 27212034
[TBL] [Abstract][Full Text] [Related]
26. CARM1-mediated methylation of protein arginine methyltransferase 5 represses human γ-globin gene expression in erythroleukemia cells.
Nie M; Wang Y; Guo C; Li X; Wang Y; Deng Y; Yao B; Gui T; Ma C; Liu M; Wang P; Wang R; Tan R; Fang M; Chen B; He Y; Huang DCS; Ju J; Zhao Q
J Biol Chem; 2018 Nov; 293(45):17454-17463. PubMed ID: 30257864
[TBL] [Abstract][Full Text] [Related]
27. PRMT5 promotes colorectal cancer growth by interaction with MCM7.
Li X; Wang X; Zhao J; Wang J; Wu J
J Cell Mol Med; 2021 Apr; 25(7):3537-3547. PubMed ID: 33675123
[TBL] [Abstract][Full Text] [Related]
28. ARID1A deficiency in EBV-positive gastric cancer is partially regulated by EBV-encoded miRNAs, but not by DNA promotor hypermethylation.
Kase K; Saito M; Nakajima S; Takayanagi D; Saito K; Yamada L; Ashizawa M; Nakano H; Hanayama H; Onozawa H; Okayama H; Endo H; Fujita S; Sakamoto W; Saze Z; Momma T; Mimura K; Ohki S; Shiraishi K; Kohno T; Kono K
Carcinogenesis; 2021 Feb; 42(1):21-30. PubMed ID: 33196828
[TBL] [Abstract][Full Text] [Related]
29. Protein arginine methyltransferase 5 (PRMT5) inhibition induces lymphoma cell death through reactivation of the retinoblastoma tumor suppressor pathway and polycomb repressor complex 2 (PRC2) silencing.
Chung J; Karkhanis V; Tae S; Yan F; Smith P; Ayers LW; Agostinelli C; Pileri S; Denis GV; Baiocchi RA; Sif S
J Biol Chem; 2013 Dec; 288(49):35534-47. PubMed ID: 24189068
[TBL] [Abstract][Full Text] [Related]
30. Downregulated microRNA-150 upregulates IRX1 to depress proliferation, migration, and invasion, but boost apoptosis of gastric cancer cells.
Wu D; Li Z; Zhao S; Yang B; Liu Z
IUBMB Life; 2020 Mar; 72(3):476-491. PubMed ID: 31846199
[TBL] [Abstract][Full Text] [Related]
31. PRMT5 regulates cell pyroptosis by silencing CASP1 in multiple myeloma.
Xia T; Liu M; Zhao Q; Ouyang J; Xu P; Chen B
Cell Death Dis; 2021 Sep; 12(10):851. PubMed ID: 34531375
[TBL] [Abstract][Full Text] [Related]
32. PKNOX2 suppresses gastric cancer through the transcriptional activation of IGFBP5 and p53.
Zhang L; Li W; Cao L; Xu J; Qian Y; Chen H; Zhang Y; Kang W; Gou H; Wong CC; Yu J
Oncogene; 2019 Jun; 38(23):4590-4604. PubMed ID: 30745575
[TBL] [Abstract][Full Text] [Related]
33. Ras association domain family member 10 suppresses gastric cancer growth by cooperating with GSTP1 to regulate JNK/c-Jun/AP-1 pathway.
Li X; Liang Q; Liu W; Zhang N; Xu L; Zhang X; Zhang J; Sung JJ; Yu J
Oncogene; 2016 May; 35(19):2453-64. PubMed ID: 26279301
[TBL] [Abstract][Full Text] [Related]
34. DNA methyltransferase 3A promotes cell proliferation by silencing CDK inhibitor p18INK4C in gastric carcinogenesis.
Cui H; Zhao C; Gong P; Wang L; Wu H; Zhang K; Zhou R; Wang L; Zhang T; Zhong S; Fan H
Sci Rep; 2015 Sep; 5():13781. PubMed ID: 26350239
[TBL] [Abstract][Full Text] [Related]
35. CAPG enhances breast cancer metastasis by competing with PRMT5 to modulate STC-1 transcription.
Huang S; Chi Y; Qin Y; Wang Z; Xiu B; Su Y; Guo R; Guo L; Sun H; Zeng C; Zhou S; Hu X; Liu S; Shao Z; Wu Z; Jin W; Wu J
Theranostics; 2018; 8(9):2549-2564. PubMed ID: 29721098
[TBL] [Abstract][Full Text] [Related]
36. Epigenetic silencing of DACH1 induces the invasion and metastasis of gastric cancer by activating TGF-β signalling.
Yan W; Wu K; Herman JG; Brock MV; Zhou Y; Lu Y; Zhang Z; Yang Y; Guo M
J Cell Mol Med; 2014 Dec; 18(12):2499-511. PubMed ID: 24912879
[TBL] [Abstract][Full Text] [Related]
37. CDCA3 is a potential prognostic marker that promotes cell proliferation in gastric cancer.
Zhang Y; Yin W; Cao W; Chen P; Bian L; Ni Q
Oncol Rep; 2019 Apr; 41(4):2471-2481. PubMed ID: 30816466
[TBL] [Abstract][Full Text] [Related]
38. Arginine methyltransferase inhibitor 1 inhibits gastric cancer by downregulating eIF4E and targeting PRMT5.
Zhang B; Zhang S; Zhu L; Chen X; Zhao Y; Chao L; Zhou J; Wang X; Zhang X; Ma N
Toxicol Appl Pharmacol; 2017 Dec; 336():1-7. PubMed ID: 28987382
[TBL] [Abstract][Full Text] [Related]
39. Down-regulation of dual-specificity phosphatase 5 in gastric cancer by promoter CpG island hypermethylation and its potential role in carcinogenesis.
Shin SH; Park SY; Kang GH
Am J Pathol; 2013 Apr; 182(4):1275-85. PubMed ID: 23402999
[TBL] [Abstract][Full Text] [Related]
40. Human SWI/SNF-associated PRMT5 methylates histone H3 arginine 8 and negatively regulates expression of ST7 and NM23 tumor suppressor genes.
Pal S; Vishwanath SN; Erdjument-Bromage H; Tempst P; Sif S
Mol Cell Biol; 2004 Nov; 24(21):9630-45. PubMed ID: 15485929
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
